John Overdeck’s Regencell Bioscience RGC Stock Holding History

John Overdeck’s Portfolio RGC Stock Details RGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$87.7K	Buy	+14,406	New	+$346K	﹤0.01%	4909

Other funds holding RGC

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

John Overdeck's RGC Position: Q2 2026 in Review

John Overdeck opened a new position in Regencell Bioscience (RGC) in Q2 2026: 14,406 shares worth $87.7K. The stake represents ﹤0.01% of the portfolio and ranks #4909 among its holdings.

35 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

John Overdeck held 14,406 shares of Regencell Bioscience worth $87.7K as of Q2 2026.
Regencell Bioscience was a new John Overdeck position in Q2 2026.
Regencell Bioscience made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4909 holding.
35 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.